Invivoscribe
Andrew Schut is an experienced clinical research professional currently serving as the Associate Director of Clinical Affairs at Invivoscribe since January 2021, where responsibilities include leading the global clinical research program for the development and approval of in vitro diagnostic products. Previously, Andrew held the position of Senior Manager of Clinical Research at Metronom Health, focusing on clinical strategy and operations for a Continuous Glucose Monitoring System development program. Andrew also worked as a Clinical Research Manager at Johnson & Johnson within the Cardiovascular & Specialty Solutions Group, and as Senior Director of Clinical Research at Pacira Pharmaceuticals, leading Phase I-III clinical studies. Earlier experience includes serving as Director of Clinical Operations at Svelte Medical Systems, overseeing the company's worldwide clinical research program. Andrew earned a Bachelor of Arts degree in Biological Basis of Behavior from the University of Pennsylvania.
This person is not in any teams
This person is not in any offices
Invivoscribe
Invivoscribe is an industry pioneer with over 20 years of experience developing and manufacturing diagnostic products and reagents.